- Home
- BTAI vs CLST Comparison
BTAI vs CLST Comparison
Compare BTAI & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- CLST
- Stock Information
- Founded
- BTAI 2017
- CLST 1922
- Country
- BTAI United States
- CLST United States
- Employees
- BTAI 37
- CLST N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- CLST
- Sector
- BTAI Health Care
- CLST
- Exchange
- BTAI Nasdaq
- CLST Nasdaq
- Market Cap
- BTAI 41.8M
- CLST 54.6M
- IPO Year
- BTAI 2018
- CLST N/A
- Fundamental
- Price
- BTAI $2.12
- CLST $15.05
- Analyst Decision
- BTAI Buy
- CLST
- Analyst Count
- BTAI 5
- CLST 0
- Target Price
- BTAI $32.80
- CLST N/A
- AVG Volume (30 Days)
- BTAI 691.3K
- CLST 9.1K
- Earning Date
- BTAI 11-12-2025
- CLST 10-23-2025
- Dividend Yield
- BTAI N/A
- CLST N/A
- EPS Growth
- BTAI N/A
- CLST N/A
- EPS
- BTAI N/A
- CLST 0.60
- Revenue
- BTAI $752,000.00
- CLST $11,340,000.00
- Revenue This Year
- BTAI N/A
- CLST N/A
- Revenue Next Year
- BTAI $544.99
- CLST N/A
- P/E Ratio
- BTAI N/A
- CLST $25.23
- Revenue Growth
- BTAI N/A
- CLST 133.67
- 52 Week Low
- BTAI $1.17
- CLST $10.67
- 52 Week High
- BTAI $9.26
- CLST $15.30
- Technical
- Relative Strength Index (RSI)
- BTAI 54.12
- CLST 70.17
- Support Level
- BTAI $1.72
- CLST $14.75
- Resistance Level
- BTAI $2.09
- CLST $15.00
- Average True Range (ATR)
- BTAI 0.18
- CLST 0.18
- MACD
- BTAI 0.06
- CLST 0.00
- Stochastic Oscillator
- BTAI 98.36
- CLST 100.00
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.